Ovid Therapeutics
OVID
OVID
49 hedge funds and large institutions have $41.9M invested in Ovid Therapeutics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
20
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$3.45M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$444K |
| 3 |
Millennium Management
New York
|
+$432K |
| 4 |
CI
Cowen Inc
New York
|
+$255K |
| 5 |
State Street
Boston,
Massachusetts
|
+$244K |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$3.08M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.69M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.44M |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$948K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$660K |
